Kim, Tae Won
Elme, Anneli
Kusic, Zvonko
Park, Joon Oh
Udrea, Anghel Adrian
Kim, Sun Young
Ahn, Joong Bae
Valencia, Ricardo Villalobos
Krishnan, Srinivasan
Bilic, Ante
Manojlovic, Nebojsa
Dong, Jun
Guan, Xuesong
Lofton-Day, Catherine
Jung, A Scott
Vrdoljak, Eduard
Article History
Received: 2 June 2016
Revised: 11 August 2016
Accepted: 7 September 2016
First Online: 13 October 2016
Competing interests
: TWK has received honoraria from Merck Serono, has served as a consultant for Amgen Inc. and Taiho, and has received research funding from Merck Sharp & Dohme and Roche. AE has received honoraria from Roche and Eli Lilly, has served as a consultant for Amgen Inc. and Roche, and has received travel expenses from Amgen Inc. and Roche. JOP has received honoraria from Celgene, has served as a consultant for Celgene and Agios Pharmaceuticals, Inc., and has received research funding from Celgene and AstraZeneca. AAU has served as a consultant for Amgen Inc., Bristol-Myers Squibb, and Teva, and has received travel expenses from Astellas and Teva. SYK has received honoraria from Roche Korea and Ildong Pharmaceutical and has served as a consultant for Bayer Korea. RVV has provided expert testimony on behalf of and received travel expenses from Pfizer, AstraZeneca and Roche. JD is an employee of, has received travel expenses from, and owns stock in Amgen Inc. XG is an employee of and owns stock in Amgen Inc., and has an immediate family member who is an employee of and owns stock in Novartis. CL-D and ASJ are employees of and own stock in Amgen Inc. EV has served as a consultant for Roche, Merck, Amgen Inc., Pfizer, Novartis, Boehringer Ingelheim and AstraZeneca, has served on speakers’ bureaus for Pfizer, Roche, Amgen Inc. and AstraZeneca, and has received travel expenses from Roche and Pfizer. ZK, JBA, SK, AB and NM have nothing to disclose.